We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+23.78%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$185M
AUM Growth
+$16.5M
(+9.8%)
Cap. Flow
-$100M
Cap. Flow
% of AUM
-54.06%
Top 10 Holdings %
Top 10 Hldgs %
35.61%
Holding
185
New
26
Increased
36
Reduced
26
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ELVA
Electrovaya
ELVA
|
+$2.28M |
| 2 |
PROF
Profound Medical
PROF
|
+$1.53M |
| 3 |
SCPH
scPharmaceuticals
SCPH
|
+$1.33M |
| 4 |
LivePerson
LPSN
|
+$1.23M |
| 5 |
Red Cat Holdings
RCAT
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aviat Networks
AVNW
|
+$2.34M |
| 2 |
Everspin Technologies
MRAM
|
+$2.08M |
| 3 |
Markel Group
MKL
|
+$1.23M |
| 4 |
Broadwind
BWEN
|
+$793K |
| 5 |
argenx
ARGX
|
+$737K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.35% |
| 2 | Technology | 13.11% |
| 3 | Financials | 6.55% |
| 4 | Industrials | 6.29% |
| 5 | Real Estate | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLT
26
DELISTED
Applied Therapeutics
APLT
| $1.38M | 0.75% |
412,981
+219,008
| +113% | +$545K |
|
|
PROF
27
Profound Medical
PROF
$268M
| $1.37M | 0.74% |
+160,971
| New | +$1.53M |
|
28
Apyx Medical
APYX
$173M
| $1.36M | 0.73% |
518,198
+55,592
| +12% | +$135K |
|
29
Delcath Systems
DCTH
$422M
| $1.22M | 0.66% |
+294,248
| New | +$964K |
|
30
Microchip Technology
MCHP
$40.3B
| $1.19M | 0.64% |
13,180
+5,742
| +77% | +$467K |
|
31
Lightpath Technologies
LPTH
$651M
| $1.17M | 0.63% |
929,611
| – | – |
|
|
32
Red Cat Holdings
RCAT
$1.15B
| $1.1M | 0.6% |
+1,250,997
| New | +$1.07M |
|
33
Weave Communications
WEAV
$520M
| $1.09M | 0.59% |
94,904
+23,839
| +34% | +$211K |
|
34
SoundThinking
SSTI
$100M
| $1.05M | 0.57% |
41,221
+17,841
| +76% | +$364K |
|
35
Elutia
ELUT
$37.9M
| $1.03M | 0.56% |
478,542
+463,114
| +3,002% | +$759K |
|
36
BK Technologies
BKTI
$300M
| $1M | 0.54% |
81,951
| – | – |
|
37
Abeona Therapeutics
ABEO
$366M
| $984K | 0.53% |
196,439
-84,841
| -30% | -$373K |
|
38
Cognition Therapeutics
CGTX
$79.6M
| $941K | 0.51% |
508,719
| – | – |
|
39
Silicom
SILC
$229M
| $739K | 0.4% |
40,810
-14,070
| -26% | -$259K |
|
40
Tyler Technologies
TYL
$12.7B
| $697K | 0.38% |
1,666
+117
| +8% | +$46.8K |
|
41
Coya Therapeutics
COYA
$98.3M
| $687K | 0.37% |
92,667
-41,339
| -31% | -$229K |
|
42
Arteris
AIP
$1.38B
| $647K | 0.35% |
109,921
+58,620
| +114% | +$330K |
|
43
GSI Technology
GSIT
$215M
| $629K | 0.34% |
238,269
-261,131
| -52% | -$656K |
|
44
Veru
VERU
$36M
| $616K | 0.33% |
+85,586
| New | +$759K |
|
|
ADVM
45
DELISTED
Adverum Biotechnologies
ADVM
| $590K | 0.32% |
78,435
+45,268
| +136% | +$413K |
|
46
Southwest Airlines
LUV
$22B
| $561K | 0.3% |
19,433
-2,354
| -11% | -$61.2K |
|
47
Sarepta Therapeutics
SRPT
$1.57B
| $521K | 0.28% |
5,400
-1,900
| -26% | -$182K |
|
|
CTO
48
CTO Realty Growth
CTO
$824M
| $490K | 0.27% |
28,302
+1,500
| +6% | +$25K |
|
49
Gilat Satellite Networks
GILT
$834M
| $462K | 0.25% |
75,643
| – | – |
|
50
Cardlytics
CDLX
$21.7M
| $440K | 0.24% |
4,774
-388
| -8% | -$39.4K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Worth Venture Partners held 185 positions worth $185M, up 9.8% from $169M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Worth Venture Partners withdrew a net $100M in Q4 2023, closing 56 positions and reducing 26 holdings. Its most notable exit was Aviat Networks, an estimated $2.34M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
Against the trend, Worth Venture Partners opened a new position in Electrovaya worth $2.51M.
- Worth Venture Partners's largest Q4 2023 buy was Electrovaya: 820,538 shares worth $2.51M.
- Worth Venture Partners added most to scPharmaceuticals in Q4 2023, an estimated $1.33M increase.
- Worth Venture Partners's biggest Q4 2023 reduction was Apollo Global Management, cutting an estimated $662K.
- Worth Venture Partners fully exited Aviat Networks in Q4 2023, selling an estimated $2.34M.
- Worth Venture Partners's ten largest holdings make up 36% of its $185M portfolio in Q4 2023.
- Worth Venture Partners opened 26 new positions and closed 56 in Q4 2023.
- Worth Venture Partners's portfolio value rose 9.8% quarter-over-quarter to $185M.
Based on Worth Venture Partners's 13F filing for Q4 2023, filed 9 Feb 2024.